Live data from Hacker News

How often do health insurers say no to patients? (2023)

propublica.org

101–103 of 103 posts

Re: How often do health insurers say no to patients? (2023)

#101
post #83

Earlier quoted context omitted.

Unless you are comparing a generic to a name brand in a situation where the insurance company forces the name brand that shouldn't be the case. For better or worse in your hypothetical the uninsured price legally has to be $1,000 for medicine. They can write off part of that but no one would write off 99.8% as the insurance company would sue their pants off.

> that shouldn't be the case Oh, I agree. But it is. > For better or worse in your hypothetical the uninsured price legally has to be $1,000 for medicine. No, it doesn't. https://www.nbcnews.com/health/health-news/cost-weight-loss-... "In March, Novo Nordisk cut the price of all doses of Wegovy by 23% for people paying in cash, dropping it from $650 to $499 per month for uninsured patients or those without coverage.…

Ah yes $500 vs $1,349 is exactly the same as $20 vs $1,000

Re: How often do health insurers say no to patients? (2023)

#102

Earlier quoted context omitted.

Yes. Indirectly.

Yeah. They should manage the organization that directly decides, like the current arrangement with CMS managing Medicare.

Yes but with medicare for everyone. Of course.

Re: How often do health insurers say no to patients? (2023)

#103

Earlier quoted context omitted.

Yes, but you'll often find that in a high-deductible plan the insurance company gets a "discount" of your $1k med down to $200, which they brag about in your EOB… but the medication's cash price for uninsured people would be $20. You're out of pocket $180 more than you should be, and paying the $20 cash price out of pocket means your deductible doesn't budge.

What if the medicine costs 100$ to produce, should uninsured have to pay that rather than a subsidized 20$?

Given US universities did the research for nearly every drug on the market, we've already paid for it.

Universities need to get into the drug production business

Post reply on HN